These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
762 related articles for article (PubMed ID: 16176535)
1. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone. Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535 [TBL] [Abstract][Full Text] [Related]
2. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study]. Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393 [TBL] [Abstract][Full Text] [Related]
3. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter. Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872 [TBL] [Abstract][Full Text] [Related]
4. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents. Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873 [TBL] [Abstract][Full Text] [Related]
5. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter. Kafkas NV; Patsilinakos SP; Mertzanos GA; Papageorgiou KI; Chaveles JI; Dagadaki OK; Kelesidis KM Int J Cardiol; 2007 Jun; 118(3):321-5. PubMed ID: 17049640 [TBL] [Abstract][Full Text] [Related]
6. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed. Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531 [TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of ibutilide for conversion of atrial fibrillation/flutter]. Yu Z; Xiang M; Ma C; Zhang S; Yang Y Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 42(2):212-6. PubMed ID: 23585009 [TBL] [Abstract][Full Text] [Related]
8. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter. Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796 [TBL] [Abstract][Full Text] [Related]
9. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods. Naegeli B; Straumann E; Bertel O Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188 [TBL] [Abstract][Full Text] [Related]
10. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. Gillis AM; Verma A; Talajic M; Nattel S; Dorian P; Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862 [TBL] [Abstract][Full Text] [Related]
11. Single dose of ibutilide for conversion of persistent atrial fibrillation after radiofrequency ablation. Hou Y; Fang PH; Liu J; Li XF; Hu JQ; Zhang S Chin Med J (Engl); 2011 Mar; 124(5):710-3. PubMed ID: 21518563 [TBL] [Abstract][Full Text] [Related]
12. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy. Glatter K; Yang Y; Chatterjee K; Modin G; Cheng J; Kayser S; Scheinman MM Circulation; 2001 Jan; 103(2):253-7. PubMed ID: 11208685 [TBL] [Abstract][Full Text] [Related]
14. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study. Bernard EO; Schmid ER; Schmidlin D; Scharf C; Candinas R; Germann R Crit Care Med; 2003 Apr; 31(4):1031-4. PubMed ID: 12682468 [TBL] [Abstract][Full Text] [Related]
15. Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation. Zhang N; Guo JH; Zhang HCh; Li XB; Zhang P; Xn Y Int J Clin Pract; 2005 Dec; 59(12):1395-400. PubMed ID: 16351670 [TBL] [Abstract][Full Text] [Related]
16. Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide? Varriale P; Sedighi A Clin Cardiol; 2000 Apr; 23(4):265-8. PubMed ID: 10763074 [TBL] [Abstract][Full Text] [Related]
17. Results from the Loire-Ardèche-Drôme-Isère-Puy-de-Dôme (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. Da Costa A; Thévenin J; Roche F; Romeyer-Bouchard C; Abdellaoui L; Messier M; Denis L; Faure E; Gonthier R; Kruszynski G; Pages JM; Bonijoly S; Lamaison D; Defaye P; Barthélemy JC; Gouttard T; Isaaz K; Circulation; 2006 Oct; 114(16):1676-81. PubMed ID: 17030680 [TBL] [Abstract][Full Text] [Related]
18. A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation. Kochiadakis GE; Igoumenidis NE; Hamilos ME; Marketou ME; Chlouverakis GI; Vardas PE Am J Cardiol; 2007 Jun; 99(12):1721-5. PubMed ID: 17560882 [TBL] [Abstract][Full Text] [Related]
19. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial). Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH; Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333 [TBL] [Abstract][Full Text] [Related]
20. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. Roy D; Talajic M; Dorian P; Connolly S; Eisenberg MJ; Green M; Kus T; Lambert J; Dubuc M; Gagné P; Nattel S; Thibault B N Engl J Med; 2000 Mar; 342(13):913-20. PubMed ID: 10738049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]